Currently, the manufacturing operations are being undertaken in USFDA approved Contracted Manufacturing facilities. The current volumes of some of the ingredients are in the range of 1-10 MT annually and are supplied to domestic and international customers.

Future manufacturing operations will be carried out at the Clavita’s own facilities (J.N. Pharma City, Visakhapatnam, India) which are expected to be ready by early 2017.